USFDA inspects Alembic Pharma’s Gujarat-based API facility
This was a scheduled pre-approval inspection at Gujarat’s Karkhadi-based facility and at the end of the inspection.
This was a scheduled pre-approval inspection at Gujarat’s Karkhadi-based facility and at the end of the inspection.
The Patanjali Ayurved Ltd issued a press release in connection with the media report from Haridwar on Tuesday.
The United States and Food and Drug Administration (USFDA) said in its report that the 'firm has separate production and packaging areas for exported and domestic products'.
The approved product is a generic version of MSD International's Vytorin tablets.
Alembic Pharmaceuticals on Monday said no observations were issued by US health regulator USFDA after inspection of its Baroda facility.…
